A drug that safely melts the pounds away would be a dream come true, but our analysis shows that the prescription weight loss pill Contrave is not that miracle drug. In three clinical trials, people ...
Currax Pharmaceuticals is kicking off the new year with a new direct-to-consumer campaign for its weight loss medication Contrave. The “Cravings Don’t Own Me” campaign includes the company’s ...
Researchers have a gentle warning for patients on the receiving end of 765,000 prescriptions for the weight-loss drug Contrave: The cardiovascular safety of this treatment “remains uncertain,” they ...
Updates on pipeline candidates are much-awaited events in the pharma/biotech sector as they provide investors information on the current status, efficacy and safety profile of a candidate and help ...
Contrave (naltrexone/bupropion) is a prescription drug that’s used to help with weight management in certain adults. Contrave’s cost may depend on factors such as ...
You may have seen the television commercials for the prescription weight-loss pill Contrave. Contrave is the combination of two older drugs - the antidepressant bupropion and the addiction-treatment ...
In the space of just four days the FDA has re-inflated the obesity treatment bubble: an advisory committee voted in favor of Contrave, a new diet pill from Orexigen (OREX); and the agency extended an ...
Takeda and Orexigen announced that Contrave (naltrexone HCl and bupropion HCl) extended-release tablets are now available by prescription. Contrave was approved in September 2014 as adjunct to a ...
A weight-loss drug called Contrave may be approved by the Food and Drug Administration in the coming weeks if the agency follows the advice of one of its panels, which recently weighed in on the ...
The FDA has finally approved the use of Contrave (naltrexone hydrochloride and bupropion hydrochloride tablets), manufactured by Orexigen Therapeutics, for chronic weight management. The regimen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results